✦ LIBER ✦

Current status of contrast-induced nephropathy and nephrogenic systemic fibrosis in children

✍ Scribed by Musturay Karcaaltincaba; Berna Oguz; Mithat Haliloglu

Book ID: 105941388
Publisher: Springer-Verlag
Year: 2009
Tongue: English
Weight: 86 KB
Volume: 39
Category: Article
ISSN: 0301-0449
DOI: 10.1007/s00247-009-1236-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nephrogenic systemic fibrosis versus con

Nephrogenic systemic fibrosis versus contrast-induced nephropathy: Risks and benefits of contrast-enhanced MR and CT in renally impaired patients

✍ Diego R. Martin; Richard C. Semelka; Arlene Chapman; Harm Peters; Paul J. Finn; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

## Abstract Magnetic resonance imaging (MRI) and computed tomography (CT) have become essential to diagnostic evaluation of many, or most, important medically and surgically treated diseases. It is important to consider comprehensively the implications in making decisions when choosing one or the o

Novel sorbents for removal of gadolinium

Novel sorbents for removal of gadolinium-based contrast agents in sorbent dialysis and hemoperfusion: preventive approaches to nephrogenic systemic fibrosis

✍ Wassana Yantasee; Glen E. Fryxell; George A. Porter; Kanda Pattamakomsan; Vichay 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 386 KB

## From the clinical editor: Chelated gadolinium (gd) contrast agents have been linked to a debilitating disease called nephrogenic systemic fibrosis (nsf) in patients with renal failure. free gd+(3) released from the contrast agents is believed to be the trigger for nsf. in this work, functionaliz

Retrospective assessment of prevalence o

Retrospective assessment of prevalence of nephrogenic systemic fibrosis (NSF) after implementation of a new guideline for the use of gadobenate dimeglumine as a sole contrast agent for magnetic resonance examination in renally impaired patients

✍ Hani H. Abujudeh; Hillary Rolls; Rathachai Kaewlai; Sheela Agarwal; Zelalem A. G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

## Abstract From May 2007 to January 2008, patients with Stage 3‐5 chronic kidney disease (CKD) undergoing gadobenate dimeglumine (GBD)‐enhanced magnetic resonance (MR) examinations were included in the retrospective investigation. The electronic medical records were reviewed to assess the prevalen